• Physician Reviewing imaging with a Patient

    WE NEVER STOP

    Discovering New Treatments. Delivering Better Outcomes. Providing Personalized Care. Focusing on You.

  • 50years

    Check Out Fox Chase’s New Annual Report

  • Tomasz Skorski, MD, PhD, DSc and Peter Abdelmessieh, DO, MSc

    This Clinical Study About Myelofibrosis Treatment Could Transform Patient Care

    World-class clinicians and researchers like Peter Abdelmessieh, Department of Bone Marrow Transplant and Cellular Therapies at Fox Chase Cancer Center, and Tomaz Skorski, MD, PhD, Dsc, Lewis Katz School of Medicine at Temple University, are driving the mission to improve survival rates for myelofibrosis patients with a promising clinical study, based on their discovery of the role of PARP inhibitors and myelofibrotic cell death.

    News

    Events

    Publications

    Link to /sites/default/files/styles/max_width/public/images/blocks/promoted/21FC063-Website-Campus-Image-360x240-1.png?itok=xO1rz-EI

    Temple Health Strong

    Fox Chase Cancer Center is proud to be an integral part of Temple Health.  Along with offering our patients the best in cancer care, we also provide unparalleled access to a vast network of physicians, specialty clinical care for a variety of other healthcare needs, and groundbreaking clinical trials and treatments.